Olusola Olusesan Faluyi

Author

Clatterbridge Cancer Centre NHS Foundation Trust ORCID

Also Known As

Ben Elliott, Faluyi, O., O Faluyi, O O Faluyi, O. Faluyi, O. O. Faluyi, O.O. Faluyi, Olusola Faluyi, Olusola O Faluyi, Olusola O. Faluyi

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Clatterbridge Cancer Centre NHS Foundation Trust University of Manchester University College London The Christie NHS Foundation Trust Weston Park Cancer Centre

About

Olusola Olusesan Faluyi is an author at Clatterbridge Cancer Centre NHS Foundation Trust specializing in oncology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.4K
2	Health Sciences	5	5	1.3K
3	Public Health	1	1	26
4	Biostatistics	1	1	22
5	Cell Biology	1	1	14

Olusola Olusesan Faluyi

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial John P. Neoptolemos, Daniel H. Palmer, Paula Ghaneh, The Lancet	2017	1.9K
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study John Primrose, Richard Fox, Daniel H. Palmer, The Lancet Oncology Surgical OncologyGastrointestinal OncologyMedicineCancer ManagementBiliary Cancer	2019	1.2K
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma Robert Jones, Eftychia‐Eirini Psarelli, Richard Jackson, JAMA Surgery	2019	256
TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial Daniel H. Palmer, Juan W. Valle, Yuk Ting, British Journal of Cancer	2020	63
Breast Radiotherapy for Occult Breast Cancer with Axillary Nodal Metastases — Does it Reduce the Local Recurrence Rate and Increase Overall Survival? S. Masinghe, Olusola Olusesan Faluyi, G.R. Kerr, Clinical Oncology Radiation MedicineRadiation TherapyOccult Breast CancerBreast RadiotherapyCancer Recurrence	2010	44
Regulation of stromal cell cyclooxygenase-2 in the Apc Min/+ mouse model of intestinal tumorigenesis Mark A. Hull, Olusola Olusesan Faluyi, C. W. Stanley Ko, Carcinogenesis	2005	29
Prognostic scores for sorafenib-treated hepatocellular carcinoma patients: A new application for the hepatoma arterial embolisation prognostic score Julien Edeline, J.F. Blanc, Boris Campillo‐Gimenez, European Journal of Cancer ThrombosisNew ApplicationHepatologyHealth SciencesMedicine	2017	28
Health utility scores from EQ-5D and health-related quality of life in patients with esophageal cancer: a real-world cross-sectional study Mark Doherty, Yvonne Leung, Jie Su, Diseases of the Esophagus Quality Of LifeLife AssessmentEsophageal CancerHealth OutcomeHealth-related Quality	2018	26
Primary esophageal and gastro-esophageal junction cancer xenograft models: clinicopathological features and engraftment Lorin Dodbiba, Jennifer Teichman, Andrew Fleet, Laboratory Investigation EsophagusAerodigestive CancerEsophageal CancerMedicineGastroenterology	2013	25
A Phase Ib Study of NUC-1031 in Combination with Cisplatin for the First-Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC-08) Mairéad G. McNamara, John Bridgewater, Daniel H. Palmer, The Oncologist	2020	24

Page 1